JP Patent

JP7391026B2 — モメタゾン及びオロパタジンの組み合わせを用いた小児対象におけるアレルギー性鼻炎の治療

Assigned to グレンマーク・スペシャルティー・エスエー · Expires 2023-12-04 · 2y expired

What this patent protects

Patent listed against Elocon.

Drugs covered by this patent

Patent Metadata

Patent number
JP7391026B2
Jurisdiction
JP
Classification
—
Expires
2023-12-04
Drug substance claim
No
Drug product claim
No
Assignee
グレンマーク・スペシャルティー・エスエー
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.